title: The effect of efavirenz versus nevirapine-containing regimens in the HIV-CAUSAL Collaboration: reply to Llibre and Podzamczer and additional results.
authors.affiliation: aDepartment of Epidemiology, Harvard School of Public Health, Boston, MA, USA bDepartment of Epidemiology, Harvard School of Public Health and Harvard-MIT Division of Health Sciences and Technology, Boston, MA, USA.
authors.forename: Lauren E
authors.initials: LE
authors.lastname: Cain
authors.forename: Miguel A
authors.initials: MA
authors.lastname: Hernán
mesh_terms: D019380:Anti-HIV Agents / Q000494:pharmacology*; D048588:Benzoxazines / Q000494:pharmacology*; D015658:HIV Infections / Q000188:drug therapy*; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D019829:Nevirapine / Q000494:pharmacology*; D018894:Reverse Transcriptase Inhibitors / Q000494:pharmacology*
chemical_list: D019380:Anti-HIV Agents; D048588:Benzoxazines; D018894:Reverse Transcriptase Inhibitors; D019829:Nevirapine